Aging Clinical Trials in Columbia, Missouri

5 studies are recruiting for aging in Columbia, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

    The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

    Stage
    EARLY_Phase 1
    Ages
    18 to 70
    Site
    University of Missouri-Columbia, Columbia, Missouri
    Run by
    University of Missouri-Columbia

    See if you can join NCT06417177 on ClinicalTrials.gov

  2. Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

    To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.

    Stage
    EARLY_Phase 1
    Ages
    18 to 70
    Site
    University of Missouri, Columbia, Missouri
    Run by
    University of Missouri-Columbia

    See if you can join NCT07674680 on ClinicalTrials.gov

  3. Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults

    During this pilot study, the investigators will examine the effects of whole-body electrical muscle stimulation exercise (WB-EMS Exercise) on motoneuronal activation in healthy adults, which typically decreases with age. The investigators will also test whether WB-EMS Exercise will improve measures…

    Stage
    Not phased
    Ages
    18 and older
    Site
    NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia, Missouri
    Run by
    University of Missouri-Columbia

    See if you can join NCT06689618 on ClinicalTrials.gov

  4. Empagliflozin Reversal of Arterial StiffnEss in Aging

    Randomized placebo-controlled clinical trial in a cohort of males (n=40) and females (n=40), 60-80 years of age, with the hypothesis that SGLT2 inhibition with empagliflozin (10mg/day for 12 weeks) reduces aging-related arterial stiffening.

    Stage
    Phase 2
    Ages
    60 to 80
    Site
    University of Missouri, Columbia, Missouri
    Run by
    University of Missouri-Columbia

    See if you can join NCT06506422 on ClinicalTrials.gov

  5. Early Neurovascular Adaptations in Aging Women

    Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.

    Stage
    EARLY_Phase 1
    Ages
    18 to 70
    Site
    University of Missouri-Columbia, Columbia, Missouri
    Run by
    University of Missouri-Columbia

    See if you can join NCT06520982 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.